1. Home
  2. CRBU vs YXT Comparison

CRBU vs YXT Comparison

Compare CRBU & YXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRBU
  • YXT
  • Stock Information
  • Founded
  • CRBU 2011
  • YXT 2011
  • Country
  • CRBU United States
  • YXT China
  • Employees
  • CRBU N/A
  • YXT N/A
  • Industry
  • CRBU Medicinal Chemicals and Botanical Products
  • YXT
  • Sector
  • CRBU Health Care
  • YXT
  • Exchange
  • CRBU Nasdaq
  • YXT NYSE
  • Market Cap
  • CRBU 151.2M
  • YXT 129.2M
  • IPO Year
  • CRBU 2021
  • YXT 2024
  • Fundamental
  • Price
  • CRBU $1.31
  • YXT $1.95
  • Analyst Decision
  • CRBU Strong Buy
  • YXT
  • Analyst Count
  • CRBU 5
  • YXT 0
  • Target Price
  • CRBU $11.80
  • YXT N/A
  • AVG Volume (30 Days)
  • CRBU 1.3M
  • YXT 17.9K
  • Earning Date
  • CRBU 03-10-2025
  • YXT 03-04-2025
  • Dividend Yield
  • CRBU N/A
  • YXT N/A
  • EPS Growth
  • CRBU N/A
  • YXT N/A
  • EPS
  • CRBU N/A
  • YXT 3.06
  • Revenue
  • CRBU $11,475,000.00
  • YXT $48,030,651.00
  • Revenue This Year
  • CRBU N/A
  • YXT N/A
  • Revenue Next Year
  • CRBU N/A
  • YXT N/A
  • P/E Ratio
  • CRBU N/A
  • YXT $0.64
  • Revenue Growth
  • CRBU N/A
  • YXT N/A
  • 52 Week Low
  • CRBU $1.22
  • YXT $1.33
  • 52 Week High
  • CRBU $8.33
  • YXT $11.00
  • Technical
  • Relative Strength Index (RSI)
  • CRBU 39.05
  • YXT N/A
  • Support Level
  • CRBU $1.30
  • YXT N/A
  • Resistance Level
  • CRBU $1.46
  • YXT N/A
  • Average True Range (ATR)
  • CRBU 0.09
  • YXT 0.00
  • MACD
  • CRBU 0.02
  • YXT 0.00
  • Stochastic Oscillator
  • CRBU 33.33
  • YXT 0.00

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies.

About YXT YXT.COM GROUP HOLDING LIMITED SPON ADS EA REP 3 CL A SHS

Yxt.Com Group Holding Ltd operates as a technology company. The company has created a SaaS model that integrates software and content, assisting customers in the digital transformation of corporate learning. The company operates in the People's Republic of China.

Share on Social Networks: